Bristol-Myers Squibb (BMY) Announces Encouraging Data from Urelumab + Opdivo Phase 1/2 in Melanoma
Go back to Bristol-Myers Squibb (BMY) Announces Encouraging Data from Urelumab + Opdivo Phase 1/2 in Melanoma| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 49.19 +0.05 (0.10%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $49.14 | 52 Week High | $77.12 | |||
| Open | $49.16 | 52 Week Low | $49.03 | |||
| Day High | $49.47 | P/E | 31.94 | |||
| Day Low | $48.96 | EPS | $1.54 | |||
| Volume | 2,284,590 | |||||
